Syros Pharmaceuticals Inc (OQ:SYRS)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for SYRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Springhorn Jeremy P. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Roth David Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Quirk Gerald E Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Olson Eric R Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Ferra Joseph J Jr Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Simonian Nancy A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 294,000  
Dec 23/19 Dec 23/19 Simonian Nancy A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -8,210  
Dec 23/19 Dec 23/19 Simonian Nancy A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,762  
Dec 23/19 Dec 23/19 Simonian Nancy A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -33,429  
Dec 23/19 Dec 23/19 Simonian Nancy A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 52,401 $3.04
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for SYRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Springhorn Jeremy P. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Roth David Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Quirk Gerald E Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Olson Eric R Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Ferra Joseph J Jr Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 94,000  
Feb 14/20 Feb 13/20 Simonian Nancy A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 294,000  
Dec 23/19 Dec 23/19 Simonian Nancy A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -8,210  
Dec 23/19 Dec 23/19 Simonian Nancy A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,762  
Dec 23/19 Dec 23/19 Simonian Nancy A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -33,429  
Dec 23/19 Dec 23/19 Simonian Nancy A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 52,401 $3.04
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $SYRS

Competitors

Competitors with Recent Insider Filings
ChemoCentryx (OQ:CCXI)
Apellis Pharmaceuticals (OQ:APLS)
Aptinyx (OQ:APTX)